Target intelligence / Profile preview

Class A serine β-lactamase (Class A β-lactamase)

Target
Class A β-lactamase
Molecular classification
Enzyme, Serine hydrolase, β-lactamase
01

Overview

Class A serine β-lactamase is a bacterial enzyme that represents the most widespread antibiotic resistance mechanism against β-lactam drugs, including penicillins and cephalosporins.[2] These enzymes function as serine-dependent hydrolases that catalyze the breakdown of β-lactam antibiotics through formation of an acyl-enzyme intermediate, utilizing conserved amino acid residues including Ser70 (catalytic residue), Glu166, and Asn170 located on the characteristic omega (Ω) loop structure.[1][3][4] Class A β-lactamases evolved from penicillin-binding proteins (PBPs) through the formation of the Ω-loop, which enables more efficient deacylation and inactivation of antibiotics compared to the original transpeptidase targets.[1] Common variants include TEM-1 (the most frequently encountered), CTX-M enzymes (extended-spectrum variants), and KPC enzymes (carbapenem-hydrolyzing variants).[3][4] As a therapeutic target, inhibiting Class A β-lactamases is critical for restoring the efficacy of β-lactam antibiotics against resistant bacterial pathogens; current approaches include mechanism-based inhibitors like clavulanate and emerging boronic acid-based non-β-lactam inhibitors designed through structure-based drug design.[2]

Other names
Serine β-lactamase class ATEM β-lactamase (for the TEM-1 representative enzyme)CTX-M β-lactamase (for extended-spectrum variants)KPC β-lactamase (for carbapenem-hydrolyzing variants)Penicillinaseβ-lactam hydrolase (serine-dependent)
02

Mechanism of action

Serine-dependent hydrolysis of β-lactam antibiotics through acyl-enzyme intermediate formation[6] Active site catalysis utilizing conserved Ser70 residue[3] Deacylation via Glu166 and Asn170 residues located on the omega (Ω) loop[1][4] Faster hydrolysis and inactivation of β-lactams compared to inhibition by penicillin-binding proteins (PBPs)[1] Formation of tetrahedral geometry at boron atoms in boronic acid complexes for inhibitor binding[2]

03

Biological functions

Bacterial antibiotic resistance through β-lactam hydrolysisPeptidoglycan cross-linking disruption (indirect)Substrate binding and catalysisAcyl-enzyme intermediate formation
04

Disease associations

Infection (bacterial resistance to β-lactam antibiotics)Healthcare-associated infectionsCommunity-acquired infections with resistant pathogens
05

Safety considerations

Rapid emergence and spread of resistance mechanisms through plasmid-encoded enzymesExtended-spectrum β-lactamase (ESBL) variants conferring resistance to third-generation cephalosporinsCarbapenem-resistant variants (KPC enzymes) limiting treatment options for serious infectionsDifficulty in developing inhibitors due to structural flexibility of the omega loop and conserved active site architecture
06

Interacting drugs

β-lactam antibiotics (substrates/inhibitory targets): penicillins, ampicillin, cephalosporins, ceftazidime, cefotaxime, ceftriaxone, cefepime, cefpirome, aztreonam

2 more in the full profile.

07

Biomarkers

Presence of Class A β-lactamase gene expression (indicates β-lactam resistance)Functional group classification (2a, 2b, 2c, 2ce for lower spectrum activity; ESBL for extended-spectrum)Omega loop composition and residue substitutions (predictors of substrate specificity)

Beyond the preview

Go deeper on Class A serine β-lactamase (Class A β-lactamase).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Class A serine β-lactamase (Class A β-lactamase).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call